This inventor holds 8 USPTO granted patents and 7 published patent applications and 3 EPO patents. Top assignee: Ablynx N.v.. Active years: 2012-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012-2020
Title: **Hilde Adi Pierrette Revets: Innovator in Biological Materials**
Introduction
Hilde Adi Pierrette Revets is a distinguished inventor based in Meise, Belgium, recognized for her impactful contributions to the field of biomedicine. With an impressive portfolio of 8 patents, Revets has made significant strides in developing biological materials with therapeutic potentials, especially in the treatment of cancers and tumors.
Latest Patents
Revets' most recent patents include innovative discoveries related to HER3 and hepatocyte growth factor (HGF). Her research concerning HER3 involves amino acid sequences that target this receptor, leading to the development of proteins and polypeptides essential for therapeutic applications. These innovations also encapsulate nucleic acids coding for such sequences and various methods for their preparation, fostering advancements in pharmaceutical compositions aimed at preventive, diagnostic, and therapeutic uses.
Moreover, her work on materials against HGF and related polypeptides illustrates her focus on cancer treatments. The objective of this invention is to inhibit the interaction between HGF and its receptor c-Met, creating promising avenues for combating malignancies.
Career Highlights
Hilde Revets is currently associated with Ablynx N.V., where she leverages her expertise to further her research endeavors. Her dedication and innovative thinking have not only contributed to her patent filings but have also helped advance the company's mission of developing novel biopharmaceuticals.
Collaborations
Throughout her career, Revets has collaborated with notable colleagues, including Hendricus Renerus Jacobus Mattheus Hoogenboom and Carlo Boutton. These collaborations have enhanced her research capabilities, providing diverse perspectives and expertise that have been pivotal to her successful patent applications.
Conclusion
Hilde Adi Pierrette Revets exemplifies the spirit of innovation in the biomedical field. Her contributions through her patents reflect a commitment to addressing critical health challenges, particularly in cancer therapy. As she continues her work at Ablynx N.V., the scientific community eagerly anticipates her future breakthroughs and the impact they will have on therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile